首页> 外国专利> SUSTAINED-RELEASE MICROSPHERE CONTAINING SHORT CHAIN DEOXYRIBONUCLEIC ACID OR SHORT CHAIN RIBONUCLEIC ACID AND METHOD OF PRODUCING THE SAME

SUSTAINED-RELEASE MICROSPHERE CONTAINING SHORT CHAIN DEOXYRIBONUCLEIC ACID OR SHORT CHAIN RIBONUCLEIC ACID AND METHOD OF PRODUCING THE SAME

机译:含有短链脱氧核糖核酸或短链核糖核酸的缓释微球及其制备方法

摘要

A sustained-release microsphere formulation containing a short chain deoxyribonucleic acid or a short chain ribonucleic acid as an active ingredient, which has improved sustained-release properties and long-lasting efficacy, is provided. A fine particle formulation, encapsulating stably a short chain deoxyribonucleic acid or a short chain ribonucleic acid, being capable of inhibiting, for a long period, expression of a specific protein related to a disease, and which can be administered by injection or transmucosally, and a production method of the same are provided. A sustained-release microsphere formulation containing a short chain deoxyribonucleic acid or a short chain ribonucleic acid, particularly siRNA, as an active ingredient, especially a sustained-release microsphere prepared through a w1/o/w2 type emulsion, is characterized in that a positively charged basic substance, such as arginine, polyethylenimine, a cell permeable peptide, poly-L-lysine or poly-L-ornithine, is included in an in vivo degradable polymer.
机译:提供了含有短链脱氧核糖核酸或短链核糖核酸作为活性成分的缓释微球制剂,其具有改善的缓释性能和长效功效。稳定地封装短链脱氧核糖核酸或短链核糖核酸的细颗粒制剂,其能够长期抑制与疾病有关的特定蛋白质的表达,并且可以通过注射或经粘膜给药,和提供了相同的制造方法。含有短链脱氧核糖核酸或短链核糖核酸,特别是siRNA作为活性成分的缓释微球制剂,特别是通过aw 1 / o / w 2 型乳剂,其特征在于体内可降解的聚合物中包含带正电荷的碱性物质,例如精氨酸,聚乙烯亚胺,可渗透细胞的肽,聚-L-赖氨酸或聚-L-鸟氨酸。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号